Skip navigation

A Guide to Dual-Action ED and PE Therapy

Dapoxetin > dapoxetin sildenafil


To view or add a comment, sign in Recent research demonstrates that gender-affirming hormone therapy can significantly alter blood protein profiles in transgender women, aligning them more closely with those of cisgender women. To view or add a comment, sign in Hereโ€™s what research shows: ๐Ÿ”น Key Study: A large 2016 study published in European Urology (by researchers from Harvard University) followed more than 30,000 men for almost two decades. They found that: โ€ข Men who ejaculated 21 or more times per month had about a 20% lower risk of developing prostate cancer than those who ejaculated 4โ€“7 times per month. ๐Ÿ”น What counts: Ejaculation frequency includes sex with a partner, masturbation, or nocturnal emissions. ๐Ÿ”น Why it may help: More frequent ejaculation may help clear potentially harmful substances from the prostate and reduce inflammation, though the exact biological reason is still being studied.

  • The demographic most commonly prescribed this combination is middle-aged men.
  • However, it can be considered for adult men of any age after proper diagnosis.
  • Efficacy and safety in elderly patients (>65) have not been extensively studied.
  • Dosing for older patients usually starts at the lowest possible amounts.
  • Age-related decline in liver and kidney function affects drug metabolism.
  • Comorbid conditions are more common in older adults, increasing interaction risks.
  • The combination is not studied or used in men with spinal cord injuries.
  • It is also not indicated for men with anatomical deformities of the penis.
  • Penile implants or other surgical interventions are alternative options.
  • The field of sexual medicine is evolving, with new treatments constantly emerging.
  • This combination represents a pragmatic approach to a complex clinical problem.

๐Ÿ”น Important context: โ€ข Itโ€™s not a prescription โ€” just a correlation, not proof of cause and effect. โ€ข Overall lifestyle (diet, exercise, weight, and not smoking) also strongly affects prostate health. โ€ข Men should still get regular prostate screenings as recommended by their doctor. โœ… Summary: Research suggests that around 21 ejaculations per month (roughly 4โ€“5 times per week) is associated with the lowest risk of prostate cancer in men, compared with lower frequencies. To view or add a comment, sign in ๐†๐‹๐-1 ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐š๐ง๐ ๐“๐ก๐ž๐ข๐ซ ๐„๐ฆ๐ž๐ซ๐ ๐ข๐ง๐  ๐‘๐จ๐ฅ๐ž ๐ข๐ง ๐€๐ฅ๐œ๐จ๐ก๐จ๐ฅ ๐š๐ง๐ ๐’๐ฎ๐›๐ฌ๐ญ๐š๐ง๐œ๐ž ๐”๐ฌ๐ž ๐ƒ๐ข๐ฌ๐จ๐ซ๐๐ž๐ซ๐ฌ: ๐€๐ง ๐„๐ง๐๐จ๐œ๐ซ๐ข๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ซ๐ข๐ฆ๐ž๐ซ Very interesting review just published in The Journal of the Endocrine Society by Nirupam Srinivasan and colleagues. โœAlcohol and other substance use disorders (ASUDs) are complex, multifaceted, but treatable medical conditions with widespread medical, psychological, and societal consequences. โœHowever, treatment options remain limited, therefore the discovery and development of new treatments for ASUDs is critical. โœGlucagon-like peptide-1 receptor agonists (GLP-1RAs), currently approved for the treatment of type 2 diabetes mellitus, obesity, and obstructive sleep apnea, have recently emerged as potential new pharmacotherapies for ASUDs. โœFollowing an overview of the epidemiology, biology, consequences, and treatments of ASUDs, this review provides a summary of the emerging role of GLP-1RAs in the treatment of ASUDs by elucidating their interactions with various neurobiological pathways involved in addiction. โœIt also highlights existing gaps in research, future directions, and broader implications related to the potential use of GLP-1RAs for addiction treatment. ๐Ÿค“ Very interesting topic and well written paper ๐Ÿค“Most of the times we talk about alcohol addiction and GLP-1RAs, however the topic si much broader. ๐Ÿค“ Preclinical studies have consistently demonstrated the potential of GLP-1RAs in reducing the consumption and rewarding properties of alcohol, opioids, nicotine, and psychostimulants. ๐Ÿค“Clinical studies remain limited for most substances but early results show reductions in cravings, substance use, and other related outcomes. Definitely worth reading!๐Ÿ‘๐Ÿ‘๐Ÿ˜€ To view or add a comment, sign in ๐†๐‹๐-1 ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐š๐ง๐ ๐“๐ก๐ž๐ข๐ซ ๐„๐ฆ๐ž๐ซ๐ ๐ข๐ง๐  ๐‘๐จ๐ฅ๐ž ๐ข๐ง ๐€๐ฅ๐œ๐จ๐ก๐จ๐ฅ ๐š๐ง๐ ๐’๐ฎ๐›๐ฌ๐ญ๐š๐ง๐œ๐ž ๐”๐ฌ๐ž ๐ƒ๐ข๐ฌ๐จ๐ซ๐๐ž๐ซ๐ฌ: ๐€๐ง ๐„๐ง๐๐จ๐œ๐ซ๐ข๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ซ๐ข๐ฆ๐ž๐ซ Very interesting review just published in The Journal of the Endocrine Society by Nirupam Srinivasan and colleagues. To view or add a comment, sign in ICD-10-CM Diagnosis Code Updates Total changes: 252 new codes, 36 deletions, 13 revisions Notable additions by chapter: Chapter 2 (Neoplasms): New codes for Hodgkin lymphoma in remission (e.g., C81.0Aโ€“C81.9A) Chapter 4 (Endocrine): Presymptomatic Type 1 diabetes (E10.A-), new obesity classifications (E66.811โ€“E66.813), and MC4R pathway-related obesity (E88.82) Chapter 5 (Mental Disorders): Expanded eating disorder codes including anorexia nervosa subtypes, binge eating disorder, pica, and rumination disorder in adults Chapter 6 (Nervous System): New epilepsy codes (e.g., G40.84 for KCNQ2-related epilepsy), serotonin syndrome (G90.81), and developmental encephalopathy (G93.45) Chapter 9 (Circulatory System): Expanded pulmonary embolism codes (I26.03โ€“I26.96) Chapter 10 (Respiratory System): New codes for nasal valve collapse under acute bronchiolitis (J21) ๐Ÿ› ๏ธ ICD-10-PCS Procedure Code Updates These updates also take effect October 1, 2025, and apply to inpatient procedures through September 30, 2026. To view or add a comment, sign in ๐Ÿ’Š Should patients really stop antidepressants before entheogen therapy?

Drug Name Class Mechanism of Action Common Uses
Dapoxetin Selective Serotonin Reuptake Inhibitor (SSRI) Increases serotonin levels in the brain Premature ejaculation treatment
Sildenafil Phosphodiesterase type 5 (PDE5) inhibitor Enhances blood flow by relaxing smooth muscles Erectile dysfunction
Tadalafil PDE5 inhibitor Longer duration of action compared to sildenafil Erectile dysfunction, BPH
Dapoxetin SSRI - Short-acting Rapid onset for premature ejaculation Premature ejaculation
Vardenafil PDE5 inhibitor Similar to sildenafil, rapid onset Erectile dysfunction
Sildenafil PDE5 inhibitor Vasodilation effect on penile blood vessels Erectile dysfunction

A new 2025 review challenges one of the fieldโ€™s most rigid assumptions. For decades, clinical trials with psilocybin, LSD, and DMT have required dapoxetine 5mg participants to discontinue antidepressants (SSRIs, SNRIs, MAOIs, etc.) weeks before an entheogen session.

Der Pharmacia Lettre

Happening October 4-5, 2025, day one of The Collaborence offers online training and connection, and day two will feature two in-person expos: one in Portland, Oregon and one in Boulder, Colorado. Be sure to check out Psychedelic Pharmacists Association members at: Day 1 October 4th Online 12:55pm โ€“ 1:40pm Psychedelics as Medicine: The Pharmacistโ€™s Perspective Colby Burns, PharmD, MBA; April Huynh; Lauren Blue, PharmD, MS. ; Andy Krut; and Anne M Berg will explore the pharmacistโ€™s role in evaluating and supporting psilocybin use for patients with complex comorbidities. Participants will walk away understanding: ๐Ÿ’Š Key pharmacologic considerations, including psilocybinโ€™s absorption, distribution, metabolism, excretion, and toxicity (ADMET), along with risks of combining psilocybin with other psychoactive or prescription substances. Special emphasis will be placed on drugโ€“drug interaction screening, including the implications of tapering or discontinuing SSRIs.

Quรก liแปu

๐Ÿ„ What to expect during a psilocybin session, with attention to physiologic and psychological warning signs that warrant intervention. ๐Ÿฅผ Pharmacistโ€™s unique role across the continuum of care: ensuring safe screening, optimizing medication management, mitigating risks, and serving as a collaborative resource for patients and care teams engaging with psilocybin therapy. Day 2 October 5th Boulder, CO ๐Ÿ”น 10:30am โ€“ 4:30pm Kristin Speer, PharmD, BCPS and Erika Beerbower will be in the exhibition hall ๐Ÿ”ธ 1:30pm - 2:15pm Beyond Psychotropics: Relevant Psilocybin Interactions You Don't Want to Miss Dr. Kristin Speer, PharmD, BCPS, Kristin Speer, PharmD, BCPS will be discussing how psilocybin drug interaction info often focuses narrowly on psychotropics such as antidepressants, antipsychotics, and lithium. This leaves important gaps in pharmacologic safety surrounding psilocybin journeys. To โ€œavoid serotonin syndromeโ€ and โ€œpreserve the full psychedelic experience.โ€ But the latest scoping review by Tap et al.

Product Dosage Quantity + Bonus Price
Priligy Generic Dapoxetine60mg180 + 10 Pills494.76โ‚ฌ 471.20โ‚ฌ
Viagra Generic50mg270 + 8 Pills198.48โ‚ฌ 189.03โ‚ฌ
Priligy Generic Dapoxetine60mg120 + 10 Pills341.26โ‚ฌ 325.01โ‚ฌ
Priligy Generic Dapoxetine60mg60 + 8 Pills183.06โ‚ฌ 174.34โ‚ฌ
Priligy Generic Dapoxetine60mg90 + 10 Pills265.64โ‚ฌ 252.99โ‚ฌ
Priligy Generic Dapoxetine60mg30 + 6 Pills106.65โ‚ฌ 101.57โ‚ฌ
Priligy Generic Dapoxetine60mg10 Pills47.63โ‚ฌ 45.36โ‚ฌ
Priligy Generic Dapoxetine60mg20 + 4 Pills77.31โ‚ฌ 73.63โ‚ฌ
Levitra Soft Tabs20mg20 Pills74.68โ‚ฌ 71.12โ‚ฌ
Levitra Generic60mg360 + 10 Pills906.69โ‚ฌ 863.51โ‚ฌ
Levitra Generic60mg270 + 10 Pills714.53โ‚ฌ 680.50โ‚ฌ
Viagra Generic100mg10 Pills28.91โ‚ฌ 27.53โ‚ฌ
Viagra Generic25mg30 + 4 Pills47.97โ‚ฌ 45.69โ‚ฌ

(2025, Journal of Psychopharmacology) suggests this protocol may be both outdated and harmful. After analyzing 19 human studies across psilocybin, LSD, DMT, and ayahuasca, the authors found that: ๐Ÿง  Safety: Thereโ€™s no robust evidence that taking antidepressants with classic entheogens increases the risk of serotonin toxicity โ€” particularly with psilocybin. Most side effects (headache, mild nausea, temporary increases in blood pressure) were comparable to placebo. ๐Ÿ’ซ Efficacy: Even when antidepressants slightly blunted the intensity of the entheogenic experience, the therapeutic outcomes for depression and anxiety remained significant.

About the Company

To view or add a comment, sign in ๐Ÿ’Š Should patients really stop antidepressants before entheogen therapy? A new 2025 review challenges one of the fieldโ€™s most rigid assumptions. For decades, clinical trials with psilocybin, LSD, and DMT have required dapoxetine 5mg participants to discontinue antidepressants (SSRIs, SNRIs, MAOIs, etc.) weeks before an entheogen session. To โ€œavoid serotonin syndromeโ€ and โ€œpreserve the full psychedelic experience.โ€ But the latest scoping review by Tap et al. (2025, Journal of Psychopharmacology) suggests this protocol may be both outdated and harmful.

Xuแบฅt tinh sแป›m

After analyzing 19 human studies across psilocybin, LSD, DMT, and ayahuasca, the authors found that: ๐Ÿง  Safety: Thereโ€™s no robust evidence that taking antidepressants with classic entheogens increases the risk of serotonin toxicity โ€” particularly with psilocybin. Most side effects (headache, mild nausea, temporary increases in blood pressure) were comparable to placebo. ๐Ÿ’ซ Efficacy: Even when antidepressants slightly blunted the intensity of the entheogenic experience, the therapeutic outcomes for depression and anxiety remained significant. In some studies, patients on antidepressants improved as much or more than those who discontinued them. โš ๏ธ Risks of discontinuation: Forcing patients to stop antidepressants can lead to relapse, withdrawal symptoms, and suicidal ideation โ€” all before entering a psychologically open and vulnerable state. In some studies, patients on antidepressants improved as much or more than those who discontinued them.

Medication Typical Dosage Administration Time Frequency
Dapoxetin 30 mg per dose 1-3 hours before sexual activity Once daily or as needed
Sildenafil 50 mg, 100 mg, or 25 mg 30-60 minutes before activity As needed, up to once daily
Tadalafil 10 mg, 20 mg, or 2.5 mg 30 minutes before activity Once daily or as needed
Vardenafil 10 mg 25-60 minutes before activity As needed
Dapoxetin 30 mg as a starting dose 1-3 hours before sexual activity As needed

โš ๏ธ Risks of discontinuation: Forcing patients to stop antidepressants can lead to relapse, withdrawal symptoms, and suicidal ideation โ€” all before entering a psychologically open and vulnerable state. In other words: the โ€œwashoutโ€ phase may do more harm than the drug combination itself.

Sildenafil Citrate + Dapoxetine HCl DC Grade

In other words: the โ€œwashoutโ€ phase may do more harm than the drug combination itself. ๐ŸŒฑ The takeaway: Continuing antidepressants during entheogen-assisted therapy may actually increase accessibility and safety for millions who currently canโ€™t participate in research or treatment. This isnโ€™t just a pharmacological question โ€” itโ€™s an ethical one. If the future of tadalafil with dapoxetine tablets mental health care is truly integrative, it must balance neurobiology with compassion, and clinical safety with real-world inclusion. Rigorous, trauma-informed trials that investigate how antidepressants modulate neuroplastic and subjective mechanisms of entheogenic therapy โ€” without retraumatizing those who rely on them daily.

Therapeutic Categories

Because healing shouldnโ€™t require withdrawal to begin. #MentalHealth #Entheogens #DepressionTreatment #Neuroplasticity #antidepressants #pharmaceuticals To view or add a comment, sign in ๐Ÿ’Š Should patients really stop antidepressants before entheogen therapy? To view or add a comment, sign in Collaborence is the signature conference of the Psilocybin Assisted Therapy Association, a national nonprofit dedicated to advancing education, collaboration, and innovation in the world of psilocybin-assisted therapy. Designed for both professionals and the public, this event brings together leading voices in mental health, psychedelic research, and community advocacy to share evidence-based insights and diverse perspectives. Through panels, discussions, and networking, attendees are empowered to make informed decisions about the role of psilocybin in their personal and professional lives, while fostering connections that build stronger, more collaborative communities. ๐ŸŒฑ The takeaway: Continuing antidepressants during entheogen-assisted therapy may actually increase accessibility and safety for millions who currently canโ€™t participate in research or treatment. This isnโ€™t just a pharmacological question โ€” itโ€™s an ethical one. If the future of tadalafil with dapoxetine tablets mental health care is truly integrative, it must balance neurobiology with compassion, and clinical safety with real-world inclusion. Rigorous, trauma-informed trials that investigate how antidepressants modulate neuroplastic and subjective mechanisms of entheogenic therapy โ€” without retraumatizing those who rely on them daily.

Why is Priligy priced so high?

โœAlcohol and other substance use disorders (ASUDs) are complex, multifaceted, but treatable medical conditions with widespread medical, psychological, and societal consequences. โœHowever, treatment options remain limited, therefore the discovery and development of new treatments for ASUDs is critical. โœGlucagon-like peptide-1 receptor agonists (GLP-1RAs), currently approved for the treatment of type 2 diabetes mellitus, obesity, and obstructive sleep apnea, have recently emerged as potential new pharmacotherapies for ASUDs. โœFollowing an overview of the epidemiology, biology, consequences, and treatments of ASUDs, this review provides a summary of the emerging role of GLP-1RAs in the treatment of ASUDs by elucidating their interactions with various neurobiological pathways involved in addiction. โœIt also highlights existing gaps in research, future directions, and broader implications related to the potential use of GLP-1RAs for addiction treatment.

CAS registry number (Chemical Abstracts Service)

๐Ÿค“ Very interesting topic and well written paper ๐Ÿค“Most of the times we talk about alcohol addiction and GLP-1RAs, however the topic si much broader. ๐Ÿค“ Preclinical studies have consistently demonstrated the potential of GLP-1RAs in reducing the consumption and rewarding properties of alcohol, opioids, nicotine, and psychostimulants. ๐Ÿค“Clinical studies remain limited for most substances but early results show reductions in cravings, substance use, and other related outcomes. Definitely worth reading!๐Ÿ‘๐Ÿ‘๐Ÿ˜€ To view or add a comment, sign in ๐†๐‹๐-1 ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐š๐ง๐ ๐“๐ก๐ž๐ข๐ซ ๐„๐ฆ๐ž๐ซ๐ ๐ข๐ง๐  ๐‘๐จ๐ฅ๐ž ๐ข๐ง ๐€๐ฅ๐œ๐จ๐ก๐จ๐ฅ ๐š๐ง๐ ๐’๐ฎ๐›๐ฌ๐ญ๐š๐ง๐œ๐ž ๐”๐ฌ๐ž ๐ƒ๐ข๐ฌ๐จ๐ซ๐๐ž๐ซ๐ฌ: ๐€๐ง ๐„๐ง๐๐จ๐œ๐ซ๐ข๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ซ๐ข๐ฆ๐ž๐ซ Very interesting review just published in The Journal of the Endocrine Society by Nirupam Srinivasan and colleagues. To view or add a comment, sign in ICD-10-CM Diagnosis Code Updates Total changes: 252 new codes, 36 deletions, 13 revisions Notable additions by chapter: Chapter 2 (Neoplasms): New codes for Hodgkin lymphoma in remission (e.g., C81.0Aโ€“C81.9A) Chapter 4 (Endocrine): Presymptomatic Type 1 diabetes (E10.A-), new obesity classifications (E66.811โ€“E66.813), and MC4R pathway-related obesity (E88.82) Chapter 5 (Mental Disorders): Expanded eating disorder codes including anorexia nervosa subtypes, binge eating disorder, pica, and rumination disorder in adults Chapter 6 (Nervous System): New epilepsy codes (e.g., G40.84 for KCNQ2-related epilepsy), serotonin syndrome (G90.81), and developmental encephalopathy (G93.45) Chapter 9 (Circulatory System): Expanded pulmonary embolism codes (I26.03โ€“I26.96) Chapter 10 (Respiratory System): New codes for nasal valve collapse under acute bronchiolitis (J21) ๐Ÿ› ๏ธ ICD-10-PCS Procedure Code Updates These updates also take effect October 1, 2025, and apply to inpatient procedures through September 30, 2026. Because healing shouldnโ€™t require withdrawal to begin. #MentalHealth #Entheogens #DepressionTreatment #Neuroplasticity #antidepressants #pharmaceuticals To view or add a comment, sign in ๐Ÿ’Š Should patients really stop antidepressants before entheogen therapy? To view or add a comment, sign in Collaborence is the signature conference of the Psilocybin Assisted Therapy Association, a national nonprofit dedicated to advancing education, collaboration, and innovation in the world of psilocybin-assisted therapy. Designed for both professionals and the public, this event brings together leading voices in mental health, psychedelic research, and community advocacy to share evidence-based insights and diverse perspectives. Through panels, discussions, and networking, attendees are empowered to make informed decisions about the role of psilocybin in their personal and professional lives, while fostering connections that build stronger, more collaborative communities. Happening October 4-5, 2025, day one of The Collaborence offers online training and connection, and day two will feature two in-person expos: one in Portland, Oregon and one in Boulder, Colorado. Be sure to check out Psychedelic Pharmacists Association members at: Day 1 October 4th Online 12:55pm โ€“ 1:40pm Psychedelics as Medicine: The Pharmacistโ€™s Perspective Colby Burns, PharmD, MBA; April Huynh; Lauren Blue, PharmD, MS. ; Andy Krut; and Anne M Berg will explore the pharmacistโ€™s role in evaluating and supporting psilocybin use for patients with complex comorbidities. Participants will walk away understanding: ๐Ÿ’Š Key pharmacologic considerations, including psilocybinโ€™s absorption, distribution, metabolism, excretion, and toxicity (ADMET), along with risks of combining psilocybin with other psychoactive or prescription substances. Special emphasis will be placed on drugโ€“drug interaction screening, including the implications of tapering or discontinuing SSRIs. ๐Ÿ„ What to expect during a psilocybin session, with attention to physiologic and psychological warning signs that warrant intervention.

  • Use dapoxetin with caution in patients with depression or anxiety.
  • Sildenafil should be used with caution in those with heart conditions.
  • Proper dosing and timing optimize safety and effectiveness.

๐Ÿฅผ Pharmacistโ€™s unique role across the continuum of care: ensuring safe screening, optimizing medication management, mitigating risks, and serving as a collaborative resource for patients and care teams engaging with psilocybin therapy.

What are the most common side effects of Priligy?

To view or add a comment, sign in Recent research demonstrates that gender-affirming hormone therapy can significantly alter blood protein profiles in transgender women, aligning them more closely with those of cisgender women. To view or add a comment, sign in Hereโ€™s what research shows: ๐Ÿ”น Key Study: A large 2016 study published in European Urology (by researchers from Harvard University) followed more than 30,000 men for almost two decades. They found that: โ€ข Men who ejaculated 21 or more times per month had about a 20% lower risk of developing prostate cancer than those who ejaculated 4โ€“7 times per month. ๐Ÿ”น What counts: Ejaculation frequency includes sex with a partner, masturbation, or nocturnal emissions. ๐Ÿ”น Why it may help: More frequent ejaculation may help clear potentially harmful substances from the prostate and reduce inflammation, though the exact biological reason is still being studied.

Dapoxetine sildenafil

๐Ÿ”น Important context: โ€ข Itโ€™s not a prescription โ€” just a correlation, not proof of cause and effect. โ€ข Overall lifestyle (diet, exercise, weight, and not smoking) also strongly affects prostate health. โ€ข Men should still get regular prostate screenings as recommended by their doctor. โœ… Summary: Research suggests that around 21 ejaculations per month (roughly 4โ€“5 times per week) is associated with the lowest risk of prostate cancer in men, compared with lower frequencies. To view or add a comment, sign in ๐†๐‹๐-1 ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐š๐ง๐ ๐“๐ก๐ž๐ข๐ซ ๐„๐ฆ๐ž๐ซ๐ ๐ข๐ง๐  ๐‘๐จ๐ฅ๐ž ๐ข๐ง ๐€๐ฅ๐œ๐จ๐ก๐จ๐ฅ ๐š๐ง๐ ๐’๐ฎ๐›๐ฌ๐ญ๐š๐ง๐œ๐ž ๐”๐ฌ๐ž ๐ƒ๐ข๐ฌ๐จ๐ซ๐๐ž๐ซ๐ฌ: ๐€๐ง ๐„๐ง๐๐จ๐œ๐ซ๐ข๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ซ๐ข๐ฆ๐ž๐ซ Very interesting review just published in The Journal of the Endocrine Society by Nirupam Srinivasan and colleagues. Day 2 October 5th Boulder, CO ๐Ÿ”น 10:30am โ€“ 4:30pm Kristin Speer, PharmD, BCPS and Erika Beerbower will be in the exhibition hall ๐Ÿ”ธ 1:30pm - 2:15pm Beyond Psychotropics: Relevant Psilocybin Interactions You Don't Want to Miss Dr. Kristin Speer, PharmD, BCPS, Kristin Speer, PharmD, BCPS will be discussing how psilocybin drug interaction info often focuses narrowly on psychotropics such as antidepressants, antipsychotics, and lithium. This leaves important gaps in pharmacologic safety surrounding psilocybin journeys. This session will explore real-world interaction examples and provide practical, science-backed strategies to reduce risks, minimize discomfort and improve outcomes.

What can I do to lower the side effects of dapoxetine?

This session will explore real-world interaction examples and provide practical, science-backed strategies to reduce risks, minimize discomfort and improve outcomes. Join us by heading to thecollaborence.org to get your ticket! To view or add a comment, sign in Department of Pharmaceutical Analysis, Grace College of Pharmacy, Kodunthirapully, Palakkad, India. Abstract: Two simple UV-Spectrophotometric methods have been developed for simultaneous determination of sildenafil citrate and dapoxetine HCl in pharmaceutical formulation. For both the methods stock solutions were prepared in methanol followed by the further required dilutions with methanol. Join us by heading to thecollaborence.org to get your ticket! To view or add a comment, sign in Department of Pharmaceutical Analysis, Grace College of Pharmacy, Kodunthirapully, Palakkad, India. Abstract: Two simple UV-Spectrophotometric methods have been developed for simultaneous determination of sildenafil citrate and dapoxetine HCl in pharmaceutical formulation. For both the methods stock solutions were prepared in methanol followed by the further required dilutions with methanol.